While continuous positive airway pressure (CPAP) therapy is the most established treatment for sleep apnea, the disorder is a prime candidate for neurostimulation treatment. To that end, soon there will be a ground breaking new therapy that assists patients that cannot comply with CPAP treatment.

Through targeted tongue-muscle stimulation, ImThera’s open-loop hypoglossal nerve multi-contact device delivers muscle tone to key tongue muscles during sleep, opening the upper airway and substantially reducing or eliminating OSA events.

Neurostimulation is a proven, well-established science, a reliable, effective means of therapy in many medical conditions. ImThera’s aura6000™ system will harness the power of neurostimulation to diminish or eliminate obstructive sleep apnea.